Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0432222 (SEM)
 47,337 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Polyactive, a polyethylene oxide/polybutylene terephthalate (PEO/PBT) copolymer, has been reported to display bone-bonding behavior. Although a detailed description of the in vivo bone/Polyactive interface is available, the underlying bone-bonding mechanism is still largely unknown. In this in vitro study, a calvarial envelope method has been adopted to reproduce the in vivo bone-bonding phenomenon and subsequently to obtain information on the biological effect of varying PEO/PBT segment ratios. The following PEO/PBT ratios were examined: 70/30, 60/40, 55/45, 40/60, and 30/70. Light microscopy (LM) and scanning (SEM), transmission (TEM), and backscatter electron microscopy (BSE), as well as X-ray microanalysis (XRMA), were employed. Within the period of analysis (3 weeks), an intimate contact between mineralized deposition and the 70/30, 60/40, and, to a lesser extent, the 55/45 surface was observed. Calcified areas developed within the surface of these PEO/BPT proportions during the culture period. Needle-shaped crystals from the mineralized tissue compartment and from calcified areas within the materials surface were intermingled at the interface, providing a morphologic continuity. A cellular layer was interposed with the mineralization front and the noncalcified 40/60 and 30/70 substrates. Apparently, the percentage of PEO is important for calcification within the near surface of the polymer. This relation is such that the higher the PEO content in PEO/PBT ratios, the more rapid the calcification. The occurrence of material calcification is considered to be largely responsible for the subsequent interfacial interactions. The calvarial envelope culture method allows not only reproduction of the in vivo bone/Polyactive interface, but also a relatively rapid differentiation within the range of PEO/PBT ratios.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Interfacial behavior of PEO/PBT copolymers (Polyactive) in a calvarial system: an in vitro study. 2690 52

The aim of the study was to prepare composites of poly(butylene terepthalate)/wollastonite (PBT/W), evaluate their properties and in vitro biocompatibility. Composites of PBT with wollastonite in two different proportions, viz. 70/30 (PW-30), 50/50 (PW-50) were prepared. The DSC studies indicate marginal changes in the melting behavior and enhanced crystallization in PBT/W composites. The mechanical properties of the composites such as tensile modulus shows remarkable improvement as a result of incorporation of wollastonite. SEM studies of fractured surfaces of impact samples showed no evidence of bonding between PBT and wollastonite. Water contact angle of PW30 and PW50 was 73.7 and 78.7, respectively. In vitro biocompatibility of PW-30 was evaluated as a representative composite. Direct cell contact test did not show deleterious effects on NIH3T3 fibroblast morphology and DNA integrity indicating its compatibility. Leach out products (LOP) of PW-30 were evaluated non-toxic as tested by MTT assay. Mouse peritoneal macrophages in contact with PW-30 showed comparable expression of CD 11b/18, CD45, CD14 and B7.2 to macrophages in contact with PTFE control indicating its non-activating nature. LOP did not induce proliferation of mouse splenic lymphocytes suggesting its immuno-tolerance. PW-30 also exhibited preliminary blood compatibility. These physical properties and biocompatibility of PBT/W composites show their suitability as potential biomaterials.
 ...
PMID:Preparation, characterization and in vitro biocompatibility evaluation of poly(butylene terephthalate)/wollastonite composites. 1137 59

Recent data suggest that mast cells (MCs) and their products are involved in the pathophysiology of thrombosis. In the present study, we analyzed the number, distribution, and phenotype of prostate MCs and periprostatic MCs in patients with unilateral periprostatic vein thrombosis (PVT) by immunohistochemical analysis and electron microscopy. MCs reacted with monoclonal antibodies to tryptase, chymase, and c-kit/CD117 and stained positively for tissue-type plasminogen activator (tPA) and urokinase receptor (uPAR/CD87) but did not express detectable urokinase (uPA) or plasminogen activator inhibitors (PAI-1, PAI-2). We found an increase in the mean +/- SEM number of MCs in PVT compared with control (PVT, 14.36 +/- 1.57 vs control, 5.23 +/- 0.57/mm2). The majority of MCs accumulated in the adventitia of thrombosed veins and showed a decrease in chymase expression. As MCs increase in number in PVT and express a profibrinolytic phenotype, we hypothesize that MC-derived molecules have a role in endogenous fibrinolysis.
 ...
PMID:Characterization of human prostate mast cells and their increase in periprostatic vein thrombosis. 1144 59

Engineering tissues in bioreactors is often hampered by disproportionate tissue formation at the surface of scaffolds. This hinders nutrient flow and retards cell proliferation and tissue formation inside the scaffold. The objective of this study was to optimize scaffold morphology to prevent this from happening and to determine the optimal scaffold geometric values for connective tissue engineering. After comparing lyophilized crosslinked collagen, compression molded/salt leached PEGT/PBT copolymer and collagen-PEGT/PBT hybrid scaffolds, the PEGT/PBT scaffold was selected for optimization. Geometric parameters were determined using SEM, microcomputed tomography, and flow permeability measurements. Fibroblast were seeded and cultured under dynamic flow conditions for 2 weeks. Cell numbers were determined using CyQuant DNA assay, and tissue distribution was visualized in H&E- and Sirius Red-stained sections. Scaffolds 0.5 and 1.5 mm thick showed bridged connected tissue from top-to-bottom, whereas 4-mm-thick scaffolds only revealed tissue ingrowth until a maximum depth of 0.6-0.8 mm. Rapid prototyped scaffold were used to assess the maximal void space (pore size) that still could be filled with tissue. Tissue bridging between fibers was only found at fiber distances < or =401 +/- 60 microm, whereas filling of void spaces in 3D-deposited scaffolds only occurred at distances < or =273 +/- 55 microm. PEGT/PBT scaffolds having similar optimal porosities, but different average interconnected pore sizes of 142 +/- 50, 160 +/- 56 to 191 +/- 69 microm showed comparable seeding efficiencies at day 1, but after 2 weeks the total cell numbers were significantly higher in the scaffolds with intermediate and high interconnectivity. However, only scaffolds with an intermediate interconnectivity revealed homogenous tissue formation throughout the scaffold with complete filling of all pores. In conclusion, significant amount of connective tissue was formed within 14 days using a dynamic culture process that filled all void spaces of a PEGT/PBT scaffolds with the following geometric parameters: thickness 1.5-1.6 mm, pore size range 90-360 microm, and average interconnecting pore size of 160 +/- 56 microm.
 ...
PMID:Synthetic scaffold morphology controls human dermal connective tissue formation. 1602 36

Porous poly(ethylene glycol) terephthalate:poly (butylene terephthalate) (PEGT:PBT) scaffolds with high PEG molecular weight (1000 g/mole) and PEGT content (60%) were fabricated using two different processes-paraffin templating and compression molding-for cartilage engineering applications. This polymer composition has previously been shown to enable chondrocyte adhesion and maintain differentiated phenotype in 2D monolayer culture. The influence of 3D polymer scaffold processing on the formation of cartilaginous tissue was studied by seeding primary immature bovine chondrocytes within cylindrical scaffolds in mixed flask reactors for 3 days, followed by cultivation in culture plates for a total of 10 or 24 days. Tissue-polymer constructs were evaluated morphologically by SEM and histology, and quantitatively for cellularity, total collagen, and glycosaminoglycan content, all of which remained statistically equivalent for each time point tested, irrespective of fabrication method. These data demonstrate that the polymers engineered for this study were able to support chondrogenesis independent of scaffold fabrication process, with the influence of pore architecture lessened by the highly hydrated scaffold microenvironments induced by high PEG content.
 ...
PMID:Evaluation of chondrogenesis within PEGT: PBT scaffolds with high PEG content. 1688 18

Among the stem cells contained in human amniotic fluid (hAF), the human amniotic fluid derived-mesenchymal stem cells (hAF-MSCs) are derived from fetal membranes and tissues that are produced during fetal development. The aim of this study was to characterize the 'stem-ness' properties of hAF-MSCs and their potency with regard to the chondrogenic differentiations using the scaffold cultivation method. This study revealed that the easily accessed and isolated MSCs were highly cell prolific and there were fewer ethical concerns regarding their usage. The MSCs were studied through the use of the alamar blue technique. In addition, after cell isolation, hAF-MSCs displayed typical MSCs morphologies including MSCs biomarker characteristics and immune privilege properties (CD44, CD73, CD90, CD105 and HLA-ABC) through immunofluorescence and flow cytometry. Interestingly, this result indicated a negative expression when using the C-Kit (CD117, tyrosine kinase receptor type III ligand for cytokine stem cell factor). This expression can be found at the cell's surface of the amniotic fluid-derived stem cells (AFSCs). This study found evidence that hAF-MSCs had the ability to differentiate the cells into the chondrogenic lineage by exhibiting chondrogenic related genes and proteins (SOX9, AGC, COL2A1 and COMP) through RT-qPCR, immunoenzymatic assays and immunofluorescence analysis. Furthermore, MSCs presented sGAGs accumulation, which was confirmed by histological analysis and SEM. Therefore, this study showed that the MSCs characteristics are contained in AF and are of significant value for further research. It appears that MSCs possess the potential for use in treatments that would necessitate the use of regenerative cell therapy.
...
PMID:Mesenchymal stem cells differentiated into chondrocyte-Like cells. 2708 49

A flame retardant named TAD was synthesized by the reaction of 9,10-Dihydro-9-oxa-10-phosphaphenanthrene-10-oxide and triallyl isocyanurate at first. Then, novel flameretarded materials based on PBT and PET resin were formulated via melt blending with TAD, expandable graphite (EG), and a mixture of both. The effect of flame retardant type and TAD content on the flame behavior of PBT/PET blend was carefully investigated. TAD contributed towards higher LOI value and better UL-94 performance than EG. However, the best V-0 rating in the UL-94 test was achieved by the incorporation of TAD/EG mixture into the resin matrix. TAD/EG combination exhibited clear synergistic effect on both reducing the flaming intensity and increasing the residual char layer, as confirmed by cone calorimeter tests and TGA results. SEM images combined with XPS analysis revealed that expansion and migration of EG locked the P-containing radicals from decomposing TAD into the condensed phase, which led to the formation of compact and continuous char layers. All the results in our studies demonstrate that incorporation of TAD with a charring agent EG is an effective and promising technique to develop flame-retarded PBT/PET material, which has high potential for applications in the areas of electronic devices, household products, and automotive parts.
 ...
PMID:Preparation and Characterization of Flame-Retarded Poly(butylene terephthalate)/Poly(ethylene terephthalate) Blends: Effect of Content and Type of Flame Retardant. 3168 25